Allopurinol riboside (Standard)
Cholic acid (Standard) is the analytical standard of Cholic acid. This product is intended for research and analytical applications. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 16220-07-8
- Formule: C10H12N4O5
- Masse moléculaire:268.23
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-101397
Allopurinol ribosideParasites Inhibitor -
HY-B0803
LumefantrineParasite Inhibitor -
HY-13801
FexinidazoleAntitrypanosomal Drug -
HY-B1548
BenznidazoleAntibiotic -
HY-17008
Toltrazuril sulfoneAnticoccidial -
HY-N7071A
Maduramicin ammoniumAntibiotic -
HY-B1177
CrotamitonTRPV4 Inhibitor -
HY-125729
Ivermectin B1bSARS-CoV Inhibitor -
HY-B0803R
Lumefantrine (Standard)Parasite Inhibitor -
HY-13801R
Fexinidazole (Standard)Antitrypanosomal Drug -
HY-117684A
Cabamiquine succinateAntimalarial Agent -
HY-N1074
WarangalonePKA Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 16220-07-8
-
Masse moléculaire 268.23
-
Formule C10H12N4O5
-
SMILES
O=C1C(C=NN2[C@H]3[C@H](O)[C@H](O)[C@@H](CO)O3)=C2N=CN1
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Nishida Y, et al. Inhibition of purine nucleoside phosphorylase activity and of T-cell function with allopurinol-riboside. Agents Actions. 1979 Dec;9(5-6):549-52. [Content Brief]
[2]. Pacher P, et al. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006 Mar;58(1):87-114. [Content Brief]
[3]. Shapiro TA, et al. Pharmacokinetics and metabolism of allopurinol riboside. Clin Pharmacol Ther. 1991 May;49(5):506-14. [Content Brief]
[4]. Were JB, et al. Effects of probenecid on the pharmacokinetics of allopurinol riboside. Antimicrob Agents Chemother. 1993 May;37(5):1193-6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Allopurinol riboside (Standard) Related Classifications
HY-101397R Related Classifications
Powered by Bioz